Magnesium Trial in Acute Asthma: Pediatric Emergency Department Study Data

A randomized double-blind placebo-controlled trial of intravenous magnesium for refractory pediatric asthma across 6 Canadian emergency departments. The dataset, 5.5 KB in size, contains results from a study enrolling 192 patients aged 2–17 years. Authored by Suzanne Schuh and last updated in 2026, it was shared under a CC-BY-4.0 license on figshare.

Use Cases

• Evaluate the efficacy of intravenous magnesium sulfate based on Pediatric Respiratory Assessment Measure (PRAM) scores mentioned in the description
• Analyze hospitalization and re-visit rates for pediatric asthma patients based on secondary outcomes described
• Compare changes in vital signs over a 3-hour period between treatment and placebo groups as outlined in the study design

Strengths

• Data originates from a randomized double-blind placebo-controlled trial, a high-evidence study design.
• The sample size of 192 patients was calculated for 80% statistical power to detect a specified effect.

Limitations

• Row count and column-level documentation are unknown, which may limit suitability assessment.
• The description indicates no results have been generated yet, suggesting the dataset may be a protocol or placeholder.

Provenance

Source

Suzanne Schuh, likely affiliated with SickKids and McMaster hospitals.

Collection Method

Data collected from a randomized controlled trial across 6 Canadian pediatric emergency departments.

Freshness

Last updated 2026-06-03 17:52:41; freshness should be verified.

Geography

Canada